These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6335692)

  • 1. Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.
    Javitch JA; Snyder SH
    Eur J Pharmacol; 1984 Nov; 106(2):455-6. PubMed ID: 6335692
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
    Sershen H; Mason MF; Debler EA; Lajtha A
    Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K; Trevor AJ; Castagnoli N
    Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS; Abell CW; Gessner W; Brossi A
    FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].
    Hirata Y; Nagatsu T
    Tanpakushitsu Kakusan Koso; 1986 Apr; 31(5):398-409. PubMed ID: 3520683
    [No Abstract]   [Full Text] [Related]  

  • 7. Potent neurotoxic fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs as potential probes in models of Parkinson disease.
    Riachi NJ; Arora PK; Sayre LM; Harik SI
    J Neurochem; 1988 Apr; 50(4):1319-21. PubMed ID: 3258018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW; Irwin I; Langston EB; Forno LS
    Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
    Heikkila RE; Sieber BA; Manzino L; Sonsalla PK
    Mol Chem Neuropathol; 1989 Jun; 10(3):171-83. PubMed ID: 2669769
    [No Abstract]   [Full Text] [Related]  

  • 10. N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria.
    Frei B; Richter C
    FEBS Lett; 1986 Mar; 198(1):99-102. PubMed ID: 3082673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
    D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
    Nature; 1987 May 28-Jun 3; 327(6120):324-6. PubMed ID: 2884568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further insight into the mode of action of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Gessner W; Brossi A; Shen RS; Abell CW
    FEBS Lett; 1985 Apr; 183(2):345-8. PubMed ID: 3872811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of recovery in MPTP-induced parkinsonism.
    Sandyk R
    Neuroscience; 1988 Nov; 27(2):727-9. PubMed ID: 3146035
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.
    Melamed E; Pikarski E; Goldberg A; Rosenthal J; Uzzan A; Conforti N
    Brain Res; 1986 Dec; 399(1):178-80. PubMed ID: 3492237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.
    Sundström E; Jonsson G
    Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture.
    Snyder SH; D'Amato RJ
    Neurology; 1986 Feb; 36(2):250-8. PubMed ID: 3080696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset.
    Gibb WR; Lees AJ; Jenner P; Marsden CD
    Neurosci Lett; 1986 Mar; 65(1):79-83. PubMed ID: 3486388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
    Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine in the extrapyramidal motor function. A study based upon the MPTP-induced primate model of parkinsonism.
    Chiueh CC
    Ann N Y Acad Sci; 1988; 515():226-38. PubMed ID: 3259118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.